American Psychiatric Association, Ed, T., & Revision (2000). Diagnostic and statistical Manual of Mental Disorders (Fourth.). Washington, DC: American Psychiatric Publishing, Inc.
Baj, G., Carlino, D., Gardossi, L., & Tongiorgi, E. (2013). Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. Frontiers in Neuroscience, 7, 188.
Boulle, F., et al. (2012). Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Molecular Psychiatry, 17(6), 584–596.
Brown, N. C., Andreazza, A. C., & Young, L. T. (2014). An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research, 218, 61–68.
Buonocore, M. H., & Maddock, R. J. (2015). Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods. Reviews in the neurosciences, 26(6), 609–632.
Camuso, S., La Rosa, P., Fiorenza, M. T., & Canterini, S. (2022). Pleiotropic effects of BDNF on the cerebellum and hippocampus: implications for neurodevelopmental disorders. Neurobiology of Disease, 163, 105606.
Clay, H. B., Sillivan, S., & Konradi, C. (2011). Mitochondrial dysfunction and Pathology in Bipolar Disorder and Schizophrenia. International Journal of Developmental Neuroscience, 29, 311–324.
Chen, Z-Y; Patel, P.D; Sant, G; Meng, C-X; Teng, K.K; Hempstead, B.L; Lee, F.S. (2004). Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons. The Journal of Neuroscience, 24(18):4401–4411.
Croarkin, P. E., Thomas, M. A., Port, J. D., Baruth, J. M., Choi, D. S., Abulseoud, O. A., & Frye, M. A. (2015). N-acetylaspartate normalization in bipolar depression after lamotrigine treatment. Bipolar Disorders, 17, 450–457.
Decoster, J., van Os, J., Kenis, G., Henquet, C., Peuskens, J., De Hert, M., & van Winkel, R. (2011). Age at Onset of psychotic disorder: Cannabis, BDNF Val66Met and sex-specific models of gene–environment Interaction. American Journal of Medical Genetics, 156, 363–369.
De-Paula, V. J., Gattaz, W. F., & Forlenza, O. V. (2016). Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations. Bipolar Disorders, 00, 1–4. https://doi.org/10.1111/bdi.12449
Di Rosa, M. C., Zimbone, S., Saab, M. W., & Tomasello, M. F. (2021). The pleiotropic potential of BDNF beyond neurons: implication for a healthy mind in a healthy body. Life, 11, 1256.
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–269.
Ehrlich, A., Schubert, F., Pehrs, C., & Gallinat, J. (2015). Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder. Psychiatry Research, 233(2), 73–80.
Frey, B. N., Walss-Bass, C., Stanley, J. A., Nery, F. G., Matsuo, K., Nicoletti, M. A., Hatch, J. P., Bowden, C. L., Escamilla, M. A., & Soares, J. C. (2007). Brain-derived neurotrophic factor val66met polymorphism a¡ects prefrontal energy metabolism in bipolar disorder. Neuroreport, 18, 1567–1570.
First, M. B., Spitzer, R. L., & Williams, J. B. (1996). Structured clinical interview for DSM-IV Axis I Disorders SCID-I. Washington, DC: American Psychiatric Press.
Fukumoto, N., Fujii, T., Combarros, O., Kamboh, M. I., Tsai, S. J., Matsushita, S., Nacmias, B., Comings, D. E., Arboleda, H., Ingelsson, M., Hyman, B. T., Akatsu, H., Grupe, A., Nishimura, A., Zatz, M., Mattila, K. M., Rinne, J., Goto, Y. I., Asada, T., Nakamura, S., & Kunugi, H. (2010). Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer’s disease: new data and meta-analysis. American Journal of Medical Genetics, 153B, 235–242.
Gallinat, G., Schubert, F., Brühl, R., Hellweg, R., Klär, A. A., Kehrer, C., Wirth, C., Sander, T., & Lang, U. E. (2010). Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage, 49, 767–771.
Gasparovic, C., Song, T., Devier, D., Bockholt, H. J., Caprihan, A., Mullins, P. G., et al. (2006). Use of tissue water as a concentration reference for proton spectroscopic imaging. Magnetic Resonance In Medicine, 55(6), 1219–1226. https://doi.org/10.1002/mrm.20901
Gruber, O., Hasan, A., Scherk, H., Wobrock, T., Schneider-Axmann, T., Ekawardhani, S., Schmitt, A., Backens, M., Reith, W., Meyer, J., & Falkai, P. (2012). Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. European Archives of Psychiatry and Clinical Neuroscience, 262, 23–31.
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. The British Journal Of Social And Clinical Psychology, 6, 278–296.
Harrisberger, F., Spalek, K., Smieskova, R., Schmidt, A., Coynel, D., Milnik, A., Fastenrath, M., Freytag, V., Gschwindc, L., Walter, A., Vogel, T., Bendfeldt, K., de Quervaina, D. J. F., Papassotiropoulos, A., & Borgwardt, S. (2014). The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data. Neuroscience and Biobehavioral Reviews, 42, 267–278.
Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H. J., Lang, U. E., Fusar-Poli, P., & Borgwardt, S. (2015). BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 55, 107–118.
Harrison, P. J., Hall, N., Mould, A., Al-Juffali, N., & Tunbridge, E. M. (2021). Cellular calcium in bipolar disorder: systematic review and meta-analysis. Molecular Psychiatry, 26, 4106–4116.
Hibar, D. P., Westlye, L. T., Doan, N. T., Jahanshad, N., Cheung, J. W., Ching, C. R. K., et al. (2017). Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA bipolar disorder Working Group. Molecular Psychiatry, 00, 1–11.
Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO Journal, 9, 2459–2464.
Hosang, G. M., Shiles, C., Tansey, K. E., Mcguffin, P., and Uher, R. (2014). Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med. 12:7. https://doi.org/10.1186/1741-7015-12-7
Karaca, M., Frigerio, F., Migrenne, S., Martin-Levilain, J., Skytt, D. M., Pajecka, K., Martin-del-Rio, R., Gruetter, R., Tamarit-Rodriguez, J., Waagepetersen, H. S., Magnan, C., & Maechler, P. (2015). GDH-Dependent glutamate oxidation in the brain dictates peripheral energy substrate distribution. Cell Reports, 13, 365–375.
Kennedy, K. G., Shahatit, Z., Dimick, M. K., Fiksenbaum, L., Freeman, N., Zai, C. C., Kennedy, J. L., MacIntosh, B. J., & Goldstein, B. I. (2021). Neurostructural correlates of BDNF rs6265 genotype in youth bipolar disorder. Bipolar Disorders, 00, 1–10.
Kowiaoski, P., Lietzau, G., Czuba, E., Waśkow, M., Steliga, A., & Moryś, J. (2017). BDNF: a key factor with multipotent impact on Brain Signaling and synaptic plasticity. Cellular and Molecular Neurobiology, 1, 15.
Kreis, R. (2004). Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. Nmr In Biomedicine, 17(6), 361–381. https://doi.org/10.1002/nbm.891
Laing, K. R., Mitchell, D., Wersching, H., Czira, M. E., Berger, K., & Baune, B. T. (2012). Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study? Age, 34, 1011–1022.
Laitinen, J., Samarut, J., Hölttä, E. (1994) A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques 17(2), 316–322.
Lang, U. E., Hellweg, R., Sander, T., & Gallinat, J. (2009). The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Molecular Psychiatry, 14, 120–122.
Li, M., Chang, H., & Xiao, X. (2016). BDNF Val66Met polymorphism and bipolar disorder in european populations: a risk association in case-control, family based and GWAS studies. Neuroscience & Biobehavioral Reviews, 68, 218–233.
Maletic, V., & Raison, C. (2014). Integrated Neurobiology of Bipolar Disorder. Frontiers in Psychiatry, 5, 98.
Mandolini, G. M., Lazzaretti, M., Pigoni, A., Delvecchio, G., Soares, J. C., & Brambilla, P. (2019). The impact of BDNF Val66Met polymorphism on cognition in bipolar disorder: a review. Journal of Affective Disorders, 243, 552–558.
Markham, A., Bains, R., Franklin, P., & Spedding, M. (2014). Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF? British Journal of Pharmacology, 171, 2206–2229.
Martens, L., Herrmann, L., Colic, L., Li, M., Richter, A., Behnisch, G., Stork, O., Seidenbecher, C., Schott, B. H., & Walter, M. (2021). Met carriers of the BDNF Val66Met polymorphism show reduced Glx/ NAA in the pregenual ACC in two independent cohorts. Scientifc Reports, 11, 6742.
Mlynárik, V., Gruber, S., & Moser, E. (2001). Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. Nmr In Biomedicine, 14(5), 325–331. https://doi.org/10.1002/nbm.713
Mitchelmore, C., & Gede, L. (2014). Brain derived neurotrophic factor: epigenetic regulation in psychiatric disorders. Brain Research, 1586, 162–172.
Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., & Kennedy, J. L. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics, 71, 651–655.
Nortje, G., Stein, D.J., Radua, J., Mataix-Cols, D., Horn, N., (2013). Systematic review and voxel-based metaanalysis of diffusion tensor imaging studies in bipolar disorder. J Affec Disor, 150, 192–200.
Pagani, R., Gasparini, A., Ielmini, M., Caselli, M., Poloni, I., Ferrari, N., Marino, M., & Callegari, F., C (2019). Twenty years of Lithium pharmacogenetics: a systematic review. Psychiatry Research, 278, 42–50.
Paul, P., Nadella, R. K., Sen, S., Ithal, D., Mahadevan, J., Reddy, Y. C. J., Jain, S., Purushottam, M., & Viswanath, B. (2021). Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in indian population. Journal of Psychopharmacology, 35(12), 1510–1516.
留言 (0)